Concepedia

John V. Cox

JV

Statistics

Publications

26

Citations

5.4K

H-Index

20

Active since

1988

Affiliations

The University of Texas Southwestern Medical Center(Current)

Texas Oncology

Palmetto Hematology Oncology

Harold C. Simmons Comprehensive Cancer Center

Parkland Health & Hospital System

John V. Cox is an author at The University of Texas Southwestern Medical Center specializing in oncology, medicine, and chemotherapy.

ORCID

Publications per year

1988–2021

26

Publications

26

Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer

Leonard B. Saltz, John V. Cox, Charles D. Blanke et al. · New England Journal of Medicine · 2000 · 3K citations · Full text

, , +13

Comparison of Oral Capecitabine Versus Intravenous Fluorouracil Plus Leucovorin as First-Line Treatment in 605 Patients With Metastatic Colorectal Cancer: Results of a Randomized Phase III Study

Paulo M. Hoff, Rafat Ansari, Gerald Batist et al. · Journal of Clinical Oncology · 2001 · 1.1K citations

, , +14

A multicenter, Phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinoma

Mace L. Rothenberg, John V. Cox, Russell F. DeVore et al. · Cancer · 1999 · 200 citations

, , +14

Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study

Mace L. Rothenberg, John V. Cox, Charles Butts et al. · Annals of Oncology · 2008 · 199 citations · Full text

, , +15

Risk of Alloimmunization and Delayed Hemolytic Transfusion Reactions in Patients With Sickle Cell Disease

John V. Cox · Archives of Internal Medicine · 1988 · 148 citations

, , +14

1–5 of 26